Tabula Rasa HealthCare to Participate in the 16th

MOORESTOWN, N.J., March 21, 2017 (GLOBE NEWSWIRE) -- Tabula Rasa HealthCare, Inc. (“TRHC”) (NASDAQ: TRHC ), a disruptive innovation and technology leader in medication safety, offering a unique Medication Risk Stratification and Medication Risk Mitigation Matrix ^® suite of decision support tools, today announced that Chairman and CEO Calvin H. Knowlton, Ph.D. and Chief Financial Officer Brian Adams, will participate in the 16 ^th Annual Needham Healthcare Conference.

Dr. Knowlton and Mr. Adams are scheduled to present at the conference on Tuesday, April 4, 2017 at 4:20 p.m. EDT. A live audio-only webcast of the presentation will be available on the investor relations section of the Company’s website at ir.trhc.com . The archived webcast and presentation materials will also be available for 90 days at the same URL.

About Tabula Rasa HealthCare

Tabula Rasa HealthCare (NASDAQ: TRHC ) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Since 2011, TRHC has focused on optimizing outcomes for PACE and other healthcare organizations through its unique Medication Risk Mitigation software and Medication Decision Support and Adherence tools that personalize each participant's medication regimen.  For more information, please visit: www.TRHC.com .

Contact: Investors Bob East or Asher Dewhurst Westwicke Partners 443-213-0500 tabularasa@westwicke.com Media Dianne Semingson 215-870-0829 dsemingson@TRHC.com